Strong Results Continue for Junior in Mexico
Source: The Critical Investor  (4/14/22)
This junior miner appears to be proving up 1 Moz heap leachable gold with ease, as further step-outs from the northern center part of its Cervantes project have returned a few excellent results. More >

Vaccine Maker Awarded Approval for COVID-19 Vaccine
Source: Streetwise Reports  (4/14/22)
Shares of Valneva SE traded 8.5% higher after the company reported that the U.K.'s MHRA has granted Conditional Marketing Authorization for its inactivated whole-virus COVID-19 vaccine candidate called VLA2001 for primary immunization in adults between 18 and 50 years old. More >

Nevada Junior Drives Higher on Long Oxide Gold Intercepts in Nevada
Source: Streetwise Reports  (4/13/22)
If you’re looking for epic gold deposits in America, you probably want to start in Nevada – home to the Carlin and Cortez trends and the country’s top gold mines. One junior explorer is hitting long intercepts of oxide gold mineralization at its flagship gold project in Nevada and it is becoming a real Butte. More >

GSK Offers $1.9B for Cancer-Focused Pharma Co.
Source: Streetwise Reports  (4/13/22)
Shares of Sierra Oncology Inc. traded 38% higher after the company reported it agreed to be acquired by GlaxoSmithKline Plc. for $55 per share in cash. More >

Investor in Digital Assets Buys 40 Plots of Virtual Land
Source: Streetwise Reports  (4/13/22)
"Tokens.com provides public investors an easy and secure way to get exposure to the most exciting and fastest growing sectors in crypto," noted a Noble Capital Markets report. More >

Software Solutions Co. Raids the Counterfeit Trade
Source: Vision and Value  (4/12/22)
This technology solutions company plans to put an end to the $3-trillion-a-year counterfeiting market. With an easy-to-use QR tool on their smartphone, consumers can confirm instantly if a product is authentic. More >

Cannabis Firm Increases YOY Revenue By 352% in 2021
  (4/12/22)
The company is expected to outperform again in 2022 given its focus on strategic growth and acquisitions, noted a Noble Capital Markets report. More >

Biopharma Firm Signs $452M License Deal for BMT Drug
Source: Streetwise Reports  (4/12/22)
Shares of Actinium Pharmaceuticals Inc. traded 24% higher after the company reported it entered into a licensing and supply agreement for its antibody radiation conjugate, Iomab-B, with Sweden's Immedica Pharma AB for sales in Europe, the Middle East and North Africa. More >

Rare Earths Crucial to Advancement of Green Economy, Defense Systems
Source: McAlinden Research  (4/12/22)
With geopolitical tensions rising, the US recently banned defense contractors from purchasing REE metals from China and will consequently attempt to revive its domestic rare earths industry. However, the US has just one rare earth mine and no processing technology, which highlights the need for a new wave of investment, writes McAlinden Research Partners. More >

Hybrid Prospect Generator Prepares for Upcoming Drill Season
Source: The Critical Investor  (4/12/22)
The Critical Investor discusses 2022 exploration plans and projects with Alianza Minerals CEO Jason Weber. More >

Helium Co. Clocks Extremely High Gas Flow
Source: Streetwise Reports  (4/11/22)
With the global helium market forecasted to reach $18.18 billion by 2025, this Canadian helium explorer is now planning an aggressive advance toward commercial production. More >

Lion One Goes Deep Into Gold Feeder Zone at Tuvatu
Source: Streetwise Reports  (4/11/22)
One junior explorer has defined a gold resource along the "Rim of Fire," a rift between tectonic plates in the South Pacific. Recent drilling has shown there is even more gold at depth. Maybe a lot more. More >

Analyst Sees 'Growth Ahead' for These 2 Gold Firms
Source: Adrian Day  (4/11/22)
Editor of Adrian Day’s Global Analyst, Adrian Day explains what he sees in the future for two gold companies and reveals his pick that had an $11.8m market value increase. More >

Novel Drug Reduces COVID-19 Deaths by 55% in Ph. 3 Trial
Source: Streetwise Reports  (4/11/22)
Shares of Veru Inc. traded 180% higher after company reported interim data from a Phase 3 clinical study of its COVID-19 drug candidate sabizabulin which was shown to reduce deaths in hospitalized patients by 55%. More >

Gold Junior Intersects High-Grade at Regnault
Source: The Critical Investor  (4/10/22)
The Critical Investor sits down with Kenorland Minerals CEO Zach Flood to discuss the company's latest exploration results from its Regnault gold project in Québec. More >

Co. Uses Protein Modulation to Treat Cancer
Source: Streetwise Reports  (4/9/22)
Nurix Therapeutics Inc. shares traded 13% higher after the company reported Q1/22 financial results and released an outline for two poster presentations that will be submitted at the American Association for Cancer Research Annual Meeting this weekend. More >

Junior Fills Treasury, Looks to Drill
Source: The Critical Investor  (4/8/22)
The Critical Investor looks at a junior miner that has been raising cash and acquiring additional claims for its Ontario projects. More >

Jr. Uranium Explorer Drills High-Grade Step-Out
Source: The Critical Investor  (4/8/22)
With the next batch of drill results from the Ivana deposit coming back from the labs including a few high-grade results, the Critical Investor discusses recent developments with Blue Sky CEO Niko Cacos. More >

Green Tech Co. to Convert Mining Waste to 'Green' Iron
Source: Streetwise Reports  (4/7/22)
This company wants to patent a process using bacteria to recover iron and other ores from millions of tonnes of mining waste. More >

‘Big Yellow’ Uranium Play Gets Bigger
Source: Streetwise Reports  (4/7/22)
The spot price for uranium has almost doubled in less than a year and the long-term price outlook looks almost as promising. One junior explorer is developing a significant uranium-vanadium project in Argentina, a country with established atomic energy infrastructure and no domestic production — yet. More >

Surgical Device Maker's Shares Rise 7% on Q3 Earnings
Source: Streetwise Reports  (4/7/22)
Shares of AngioDynamics Inc. traded higher after the company reported Q3/22 financial results highlighting a 28.6% YoY increase in net Med Tech sales. More >

Jr. Explorer Adjacent to K92’s Mine Acquires Defined Resource From Harmony Gold Mining
Source: Streetwise Reports  (4/6/22)
Kainantu Resources' properties surround K92's mine, a massive project with a 4.8 million ounce gold resource in Papua New Guinea. The deal opens the door for large miner Harmony Gold to take a strategic position in the explorer. More >

FDA Approves Bipolar and Schizophrenia Drug
Source: Streetwise Reports  (4/6/22)
BioXcel Therapeutics Inc. reported that the U.S. FDA has approved its IGALMIâ„¢ (dexmedetomidine) Sublingual Film for use in acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. More >

Technical Analyst: Drone Stock Set to Take Off
Source: Clive Maund  (4/6/22)
Technical analyst Clive Maund charted this drone company and believes that it has a very strong chart and looks to be on the verge of breaking out into a major bull market. More >

Awde, Quartermain-Backed Junior Raises $50M, Trades on NYSE
Source: Streetwise Reports  (4/5/22)
In January 1879, entrepreneur George Hearst took Homestake Mining public on the NYSE — the first mining stock ever listed. Now, 123 years later, some intrepid mining men are bringing the Homestake gold camp back to the NYSE in a new offering backed by $50M in exploration and development cash. More >